Dynamic Technology Lab Private Ltd Acquires New Holdings in Sabra Healthcare REIT, Inc. (SBRA)

Dynamic Technology Lab Private Ltd acquired a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,781 shares of the real estate investment trust’s stock, valued at approximately $259,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 6.4% during the second quarter. Vanguard Group Inc. now owns 13,229,559 shares of the real estate investment trust’s stock valued at $318,832,000 after acquiring an additional 797,491 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Sabra Healthcare REIT by 3.0% during the second quarter. BlackRock Inc. now owns 9,570,432 shares of the real estate investment trust’s stock valued at $230,649,000 after acquiring an additional 277,421 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Sabra Healthcare REIT by 294.2% during the third quarter. Bank of New York Mellon Corp now owns 4,721,303 shares of the real estate investment trust’s stock valued at $103,586,000 after acquiring an additional 3,523,631 shares in the last quarter. LSV Asset Management increased its holdings in shares of Sabra Healthcare REIT by 8.7% during the second quarter. LSV Asset Management now owns 3,019,936 shares of the real estate investment trust’s stock valued at $72,780,000 after acquiring an additional 241,022 shares in the last quarter. Finally, APG Asset Management US Inc. increased its holdings in shares of Sabra Healthcare REIT by 160.6% during the third quarter. APG Asset Management US Inc. now owns 2,874,000 shares of the real estate investment trust’s stock valued at $63,056,000 after acquiring an additional 1,771,033 shares in the last quarter. Hedge funds and other institutional investors own 85.51% of the company’s stock.

In related news, Director Milton J. Walters sold 4,615 shares of the stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $19.18, for a total value of $88,515.70. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 2.60% of the stock is currently owned by corporate insiders.

Sabra Healthcare REIT, Inc. (SBRA) opened at $19.00 on Wednesday. Sabra Healthcare REIT, Inc. has a fifty-two week low of $18.48 and a fifty-two week high of $29.10. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market cap of $3,440.00, a P/E ratio of 8.50, a P/E/G ratio of 2.52 and a beta of 0.92.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Investors of record on Wednesday, November 15th were issued a $0.07 dividend. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.28 annualized dividend and a yield of 1.47%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 266.67%.

SBRA has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Wednesday, August 9th. Jefferies Group upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 price objective on the stock in a report on Tuesday, August 15th. BidaskClub downgraded shares of Sabra Healthcare REIT from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 16th. ValuEngine downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, JMP Securities upgraded shares of Sabra Healthcare REIT from a “market perform” rating to an “outperform” rating and set a $23.00 price target on the stock in a report on Tuesday, September 5th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $24.40.

WARNING: “Dynamic Technology Lab Private Ltd Acquires New Holdings in Sabra Healthcare REIT, Inc. (SBRA)” was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.chaffeybreeze.com/2017/12/06/dynamic-technology-lab-private-ltd-acquires-new-holdings-in-sabra-healthcare-reit-inc-sbra.html.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply